-
Ascidiacyclamide
- names:
Ascidiacyclamide
- CAS号:
86701-12-4
MDL Number: - MF(分子式): C36H52N8O6S2 MW(分子量): 756.982
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|
| 中文别名 | (4S,7R,8S,11R,18S,21R,22S,25R)-4,18-bis[(2S)-butan-2-yl]-7,21-dimethyl-11,25-di(propan-2-yl)-6,20-dioxa-13,27-dithia-3,10,17,24,29,30,31,32-octazapentacyclo[24.2.1.15,8.112,15.119,22]dotriaconta-1(28),5(32),12(31),14,19(30),26(29)-hexaene-2,9,16,23-tetrone |
| 英文别名 | Ascidiacyclamide |
| CAS号 | 86701-12-4 |
| Inchi | InChI=1S/C36H52N8O6S2/c1-11-17(7)25-33-43-27(19(9)49-33)31(47)39-24(16(5)6)36-38-22(14-52-36)30(46)42-26(18(8)12-2)34-44-28(20(10)50-34)32(48)40-23(15(3)4)35-37-21(13-51-35)29(45)41-25/h13-20,23-28H,11-12H2,1-10H3,(H,39,47)(H,40,48)(H,41,45)(H,42,46)/t17-,18-,19+,20+,23+,24+,25-,26-,27-,28-/m0/s1 |
| InchiKey | QBRRPBPLIGDANJ-AXCFFLBZSA-N |
| 分子式 Formula | C36H52N8O6S2 |
| 分子量 Molecular Weight | 756.982 |
| 溶解度Solubility | |
| 性状 | Solid powder |
| 储藏条件 Storage conditions | Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years). |
| 产品说明 | Ascidiacyclamide(CAS:86701-12-4):仅限应用于工业或者科学研究过程中非医疗目的,不应用于人类或动物的临床诊断以及治过程疗,该产品非药用,非食用。 |
| Introduction | Ascidiacyclamide is a cytotoxic cyclic peptide from the marine tunicate Ascidian. |
| Application1 | |
| Application2 | |
| Application3 |
| [1]Jaspars M. The origins of cyanobactin chemistry and biology. Chem Commun (Camb). 2014 Sep 14;50(71):10174-6. doi: 10.1039/c3cc49252d. Review. PubMed PMID: 25068542. |
| [2]Comba P, Gahan LR, Hanson GR, Maeder M, Westphal M. Carbonic anhydrase activity of dinuclear Cu(II) complexes with patellamide model ligands. Dalton Trans. 2014 Feb 28;43(8):3144-52. doi: 10.1039/c3dt53135j. PubMed PMID: 24326405. |
| [3] Asano A, Minoura K, Yamada T, Doi M. Conformational transformation of ascidiacyclamide analogues induced by incorporating enantiomers of phenylalanine, 1-naphthylalanine or 2-naphthylalanine. J Pept Sci. 2016 Mar;22(3):156-65. doi: 10.1002/psc.2853. PubMed PMID: 26856689. |
| [4] Asano A, Yamada T, Doi M. Modulating the structure of phenylalanine-incorporated ascidiacyclamide through fluorination. J Pept Sci. 2014 Oct;20(10):794-802. doi: 10.1002/psc.2668. Epub 2014 Jul 1. PubMed PMID: 24985333. |
| [5] Asano A, Doi M, Kobayashi K, Arimoto M, Ishida T, Katsuya Y, Mezaki Y, Hasegawa H, Nakai M, Sasaki M, Taniguchi T, Terashima A. Effects of amino acids and chirality for molecular folding of desoxazoline-ascidiacyclamide derivatives: X-ray crystal structures of four cyclic octapeptides including unusual amino acids, cyclo(-Ile-aThr-D-Val-Thz-)(2), cyclo(-Ala-aThr-D-Val-Thz-Ile-aThr-D-Val-Thz-), cyclo(-Val-aThr-D-Val-Thz-Ile-aThr-D-Val-Thz-), and cyclo(-Ile-aThr-Val-Thz-Ile-aThr-D-Val-Thz-). Biopolymers. 2001 Mar;58(3):295-304. PubMed PMID: 11169389. |
6: Asano A, Numata S, Yamada T, Minoura K, Doi M. Conformational properties of ascydiacyclamide analogues with cyclic α-amino acids instead of oxazoline residues. Bioorg Med Chem. 2017 Dec 15;25(24):6554-6562. doi: 10.1016/j.bmc.2017.10.029. Epub 2017 Oct 26. PubMed PMID: 29097029.7: Doi M, Shinozaki F, In Y, Ishida T, Yamamoto D, Kamigauchi M, Sugiura M, Hamada Y, Kohda K, Shioiri T. Conformational change of ascidiacyclamide caused by asymmetric modification for an isoleucine residue: structural analyses of [Gly], [Leu], and [Phe]ascidiacyclamides by x-ray diffraction and NMR spectroscopy. Biopolymers. 1999 May;49(6):459-69. PubMed PMID: 10193193.8: Asano A, Yamada T, Doi M. The square conformation of phenylglycine-incorporated ascidiacyclamide is stabilized by CH/π interactions between amino acid side chains. Bioorg Med Chem. 2011 Jun 1;19(11):3372-7. doi: 10.1016/j.bmc.2011.04.036. Epub 2011 Apr 22. PubMed PMID: 21592800.9: Asano A, Yamada T, Numata A, Doi M. Cyclo(-Cha-Oxz-D-Val-Thz-Ile-Oxz-D-Val-Thz-) N,N-dimethylacetamide dihydrate: a square form of cyclohexylalanine-incorporated ascidiacyclamide having the strongest cytotoxicity. Acta Crystallogr C. 2003 Sep;59(Pt 9):o488-90. Epub 2003 Aug 9. PubMed PMID: 12944653.10: Ishida T, In Y, Doi M, Inoue M, Hamada Y, Shioiri T. Molecular conformation of ascidiacyclamide, a cytotoxic cyclic peptide from Ascidian: X-ray analyses of its free form and solvate crystals. Biopolymers. 1992 Feb;32(2):131-43. PubMed PMID: 1637988.1
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


